Denis Poddubnyy Selected Research

Sacroiliitis

6/2022	Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis.
2/2022	[Spondyloarthritis in childhood and adulthood].
1/2022	Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort.
1/2021	Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT.
11/2020	IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritis.
1/2020	Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.
12/2019	The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis.
1/2019	Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.
1/2019	Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept.
10/2017	Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Denis Poddubnyy Research Topics

Disease

54	Axial Spondyloarthritis 06/2022 - 07/2012
44	Ankylosing Spondylitis 07/2022 - 07/2011
22	Inflammation (Inflammations) 01/2022 - 05/2012
14	Sacroiliitis 06/2022 - 08/2011
10	Necrosis 11/2021 - 02/2013
10	Non-Radiographic Axial Spondyloarthritis 01/2021 - 08/2011
7	Arthritis (Polyarthritis) 09/2022 - 05/2012
6	Psoriatic Arthritis 04/2022 - 07/2011
5	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 05/2012
5	Osteitis 01/2022 - 02/2015
5	Back Pain (Backache) 12/2020 - 11/2011
4	Rheumatoid Arthritis 10/2020 - 07/2011
3	Infections 04/2022 - 01/2020
3	Pain (Aches) 01/2021 - 08/2012
2	Synovitis 09/2022 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 08/2015
2	Uveitis 06/2022 - 08/2015
2	Spondylarthritis (Spinal Arthritis) 02/2022 - 05/2012
2	Ankylosis 03/2020 - 02/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2019 - 01/2018
2	Disease Progression 01/2016 - 09/2015
1	Crohn Disease (Crohn's Disease) 10/2022
1	Tenosynovitis 09/2022
1	Spondylitis 04/2022
1	Critical Illness (Critically Ill) 01/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2022
1	COVID-19 01/2022
1	Ulcerative Colitis 01/2022
1	Fatigue 01/2022
1	Pulmonary Aspergillosis 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Vascular Diseases (Vascular Disease) 10/2020
1	Fibromyalgia (Fibrositis) 10/2020
1	Osteoporosis 10/2020
1	Nasopharyngitis 01/2020
1	Skin Diseases (Skin Disease) 01/2020

Drug/Important Bio-Agent (IBA)

18	C-Reactive ProteinIBA 01/2022 - 08/2011
13	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 08/2012
11	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 06/2013
11	Interleukin-17 (Interleukin 17)IBA 01/2021 - 02/2013
10	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2022 - 11/2011
10	secukinumabIBA 01/2022 - 08/2017
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 07/2011
8	Antirheumatic Agents (DMARD)IBA 06/2022 - 05/2012
8	Etanercept (Enbrel)FDA Link 01/2021 - 07/2012
7	Biological ProductsIBA 11/2021 - 01/2019
6	Pharmaceutical PreparationsIBA 06/2022 - 07/2012
5	InterleukinsIBA 03/2020 - 08/2017
5	Monoclonal AntibodiesIBA 03/2020 - 02/2013
4	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2021 - 07/2012
4	CytokinesIBA 01/2021 - 01/2017
4	ixekizumabIBA 01/2021 - 01/2019
4	Adalimumab (Humira)FDA Link 03/2020 - 07/2011
3	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 12/2019
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2014
3	AdiponectinIBA 01/2022 - 03/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	AdipokinesIBA 01/2022 - 03/2015
3	FibrinIBA 01/2021 - 01/2020
2	bimekizumabIBA 07/2022 - 01/2020
2	Leflunomide (Arava)FDA LinkGeneric 04/2022 - 03/2022
2	LeptinIBA 01/2022 - 01/2017
2	tofacitinibIBA 01/2022 - 11/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2019
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022 - 09/2014
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2022 - 03/2015
2	Fibrinogen (Factor I)FDA Link 01/2021 - 12/2020
2	Janus Kinase InhibitorsIBA 01/2021 - 01/2020
2	Factor XIII (Coagulation Factor XIII)IBA 01/2021 - 12/2020
2	AntibodiesIBA 11/2020 - 01/2018
2	Interleukin-23 (Interleukin 23)IBA 01/2020 - 12/2019
2	Interleukin-12 (IL 12)IBA 01/2020 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2018
2	HLA-C Antigens (HLA-C)IBA 11/2019 - 11/2019
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2015 - 05/2012
1	IodineIBA 09/2022
1	Fluspirilene (Imap)IBA 09/2022
1	spiropentaneacetic acid (SPAA)IBA 02/2022
1	OsteoprotegerinIBA 01/2022
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	OsteocalcinIBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Procollagen Type IIBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 11/2020
1	CollagenIBA 10/2020
1	Biosimilar PharmaceuticalsIBA 03/2020
1	GlucocorticoidsIBA 01/2020

Therapy/Procedure

22	Therapeutics 04/2022 - 07/2011
1	Aftercare (After-Treatment) 06/2022
1	Duration of Therapy 06/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Activities of Daily Living (ADL) 03/2020
1	Injections 01/2020